IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer
暂无分享,去创建一个
Andrew Wang | Lily Yang | Hui Mao | Weiping Qian | Zhiyang Zhou | Hongyu Zhou | Fatih M Uckun | Liya Wang | Lily Yang | Hongyu Zhou | F. Uckun | H. Mao | A. Wang | Liya Wang | W. Qian | Zhiyang Zhou | Andrew Wang
[1] A. Sartorelli,et al. Function of the anthracycline amino group in cellular transport and cytotoxicity. , 1987, Molecular pharmacology.
[2] Hong Xu,et al. Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors. , 2014, Small.
[3] Stan W. Casteel,et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity , 2010, Proceedings of the National Academy of Sciences.
[4] Domenico Coppola,et al. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. , 2003, Human pathology.
[5] Hua Ai,et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.
[6] I. Tannock,et al. Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.
[7] Huan Meng,et al. Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. , 2013, ACS nano.
[8] G. Hannon,et al. Patient-derived tumor xenografts: transforming clinical samples into mouse models. , 2013, Cancer research.
[9] Manuel Hidalgo,et al. Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas , 2012, Clinical Cancer Research.
[10] S. Kopetz,et al. The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men , 2012, Clinical Cancer Research.
[11] Shuming Nie,et al. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. , 2013, ACS nano.
[12] Kenichi Suda,et al. The insulin‐like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild‐type epidermal growth factor receptor , 2014, International journal of cancer.
[13] Derek S. Chan,et al. The Pancreas Cancer Microenvironment , 2012, Clinical Cancer Research.
[14] Jerry S. H. Lee,et al. Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.
[15] Aik Choon Tan,et al. Patient-derived tumour xenografts as models for oncology drug development , 2012, Nature Reviews Clinical Oncology.
[16] Hongyu,et al. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. , 2015, ACS nano.
[17] Jinho Park,et al. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.
[18] Tatsuo Ohira,et al. Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer , 2013, Cellular Oncology.
[19] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[20] M. D. Blanco,et al. Targeted Nanoparticles for Cancer Therapy , 2012 .
[21] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[22] H. Dai,et al. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] Alexander A. Fingerle,et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications , 2012, Nature Reviews Gastroenterology &Hepatology.
[24] Gabriele Bergers,et al. Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.
[25] Stephen C Peiper,et al. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma , 2012, Cancer.
[26] Hua Ai,et al. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. , 2011, Accounts of chemical research.